Table 2.
Literature | Compounds | Tyrosinase Inhibitory Effects | Enzymes and Substrates Used |
||
---|---|---|---|---|---|
Name | Chemical Structure | Monophenolase Activity |
Diphenolase Activity |
||
[89] | α-arbutin | 3 | IC50 = 2.1 mM | Human tyrosinase; 3.3 mM L-DOPA |
|
Arbutin | 2 | IC50 > 30 mM | |||
4-Hydroxyphenyl β-maltoside | 7 | IC50 = 5.7 mM | |||
4-Hydroxyphenyl β-maltotrioside | 8 | IC50 = 6.1 mM | |||
[90] | 4-Hydroxyphenyl α-maltoside | 11 | IC50 = 4.9 mM | Human tyrosinase; 3.3 mM L-DOPA |
|
4-Hydroxyphenyl α-maltotrioside | 12 | IC50 = 13.9 mM | |||
[91] | Arbutin | 2 | Ki = 2.8 mM | Mushroom tyrosinase; 3.3 mM DOPA |
|
4-Hydroxyphenyl β-isomaltoside | 9 | Ki = 3.7 mM | |||
4-Hydroxyphenyl β-isomaltotrioside | 10 | Not determined | |||
[92] | Arbutin | 2 | IC50 = 6 mM | Mushroom tyrosinase; 0.03% L-tyrosine |
|
β-D-Glucopyranosyl-(1→6)-arbutin | 4 | IC50 = 8 mM | |||
β-D-Glucopyranosyl-(1→4)-arbutin | 5 | IC50 = 10 mM | |||
β-D-Glucopyranosyl-(1→3)-arbutin | 6 | IC50 = 5 mM | |||
α-D-Glucopyranosyl-(1→4)-arbutin | 7 | IC50 = 5 mM | |||
[93] | α-arbutin | 3 | IC50 = 2.1 mM | Human tyrosinase; 3 mM L-DOPA |
|
α-arbutin-α-glucoside | 11 | IC50 = 6.9 mM | |||
α-arbutin-α-maltoside | 12 | IC50 = 15.6 mM | |||
α-arbutin-α-maltotrioside | 13 | Not determined |